Epilepsy
Epilepsy is a neurological disorder that causes recurrent seizures due to abnormal electrical activity in the brain. It can manifest in various forms, leading to symptoms such as convulsions, loss of consciousness, and unusual sensations.
Severe Epilepsy: Cannabidiol Oral Solution
We are studying whether Cannabidiol can help reduce seizures in children and young adults with rare disease-related severe epilepsy. The trial also looks at safety and how it interacts with current medications.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 2 and 25 years old?
- Do you have severe epilepsy with at least 4 seizures per month?
- Are you currently taking at least 1 antiseizure medication (like Keppra or Lamictal)?
- Are you pregnant or planning to become pregnant during the study?
- Have you used cannabis or cannabinoid-based medications in the last 3 months?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Avidekel/ Tikun
Davikel
Erevron
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Azienda Ospedaliero Universitaria Meyer IRCCS
Center of Excellence of Neuroscience
Florence, Italy
Sponsor: Azienda Ospedaliero Universitaria Meyer IRCCS
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.